UY31692A - Formulacion en suspension para adsorbentes de carbono - Google Patents

Formulacion en suspension para adsorbentes de carbono

Info

Publication number
UY31692A
UY31692A UY0001031692A UY31692A UY31692A UY 31692 A UY31692 A UY 31692A UY 0001031692 A UY0001031692 A UY 0001031692A UY 31692 A UY31692 A UY 31692A UY 31692 A UY31692 A UY 31692A
Authority
UY
Uruguay
Prior art keywords
suspension formulation
carbon adsorbents
moisturizer
fixing
gastrointestinal tract
Prior art date
Application number
UY0001031692A
Other languages
English (en)
Inventor
Behrend Dr Olaf
Heep Dr Iris
Kowollik Dr Nikolaus
Mertin Dr Dirk
Ohage-Spitzlei Petra
Schmidt Dr Bernard
Wiehl Dr Wolfgang
Original Assignee
Bayer Animal Health Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Animal Health Gmbh filed Critical Bayer Animal Health Gmbh
Publication of UY31692A publication Critical patent/UY31692A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/44—Elemental carbon, e.g. charcoal, carbon black
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Inorganic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Carbon And Carbon Compounds (AREA)

Abstract

La invención se refiere a una formulación en suspensión acuosa que comprende un adsorbente de carbono en forma de partículas de modo grueso que es adecuado para fijar y eliminar sustancias perjudiciales del tracto gastrointestinal, y un agente formador de estructura soluble en agua o dispersable en agua y un humectante.
UY0001031692A 2008-03-13 2009-03-05 Formulacion en suspension para adsorbentes de carbono UY31692A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102008014109A DE102008014109A1 (de) 2008-03-13 2008-03-13 Suspensionsformulierung für Kohlenstoff-Adsorbentien

Publications (1)

Publication Number Publication Date
UY31692A true UY31692A (es) 2009-11-10

Family

ID=40823009

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001031692A UY31692A (es) 2008-03-13 2009-03-05 Formulacion en suspension para adsorbentes de carbono

Country Status (17)

Country Link
US (1) US20110021641A1 (es)
EP (1) EP2265254A2 (es)
JP (1) JP2011513448A (es)
KR (1) KR20100135760A (es)
CN (1) CN101969925A (es)
AR (1) AR070974A1 (es)
AU (1) AU2009225055A1 (es)
BR (1) BRPI0908576A2 (es)
CA (1) CA2718142A1 (es)
CL (1) CL2009000538A1 (es)
DE (1) DE102008014109A1 (es)
MX (1) MX2010008982A (es)
PE (1) PE20091578A1 (es)
TW (1) TW200950791A (es)
UY (1) UY31692A (es)
WO (1) WO2009112169A2 (es)
ZA (1) ZA201006082B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2586135T3 (es) 2010-02-23 2016-10-11 Da Volterra Formulaciones para el suministro oral de adsorbentes en el intestino
JP5739659B2 (ja) * 2010-12-27 2015-06-24 アピ株式会社 腸内有害物質吸着剤及びその製造方法
ES2467566B1 (es) * 2012-12-12 2015-01-22 Lainco, S.A. Composición farmacéutica de carbón activado en suspensión

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3917821A (en) * 1973-10-23 1975-11-04 Milton Manes Palatable activated carbon
JPS5673542A (en) * 1979-11-22 1981-06-18 Kureha Chem Ind Co Ltd Adsorbent
US5958458A (en) * 1994-06-15 1999-09-28 Dumex-Alpharma A/S Pharmaceutical multiple unit particulate formulation in the form of coated cores
JP3522708B2 (ja) * 2001-04-11 2004-04-26 呉羽化学工業株式会社 経口投与用吸着剤
US6830753B2 (en) * 2001-04-11 2004-12-14 Kureha Chemical Industry Co., Ltd. Adsorbent for oral administration
ES2285203T3 (es) * 2002-11-01 2007-11-16 Kureha Corporation Adsorbentes para administracion oral, curativos o preventivos para enfermedades renales y curativos o preventivos para enfermedades hepaticas.
CN1615908B (zh) 2003-10-22 2011-09-28 株式会社吴羽 口服给药用吸附剂、以及肾病治疗或预防剂、和肝病治疗或预防剂
JP2006273772A (ja) * 2005-03-30 2006-10-12 Japan Organo Co Ltd 経口投与薬及びその製造方法
FR2904238B1 (fr) * 2005-04-14 2010-10-29 Serb Procede de production de suspensions de produits finement pulverulents, moyen destine a cet effet et les compositions pharmaceutiques contenant ces produits finement pulverulents
EP1886689A4 (en) * 2005-05-16 2009-07-22 Kureha Corp INHIBITOR OF OXIDATIVE STRESS
DE202005011296U1 (de) * 2005-07-18 2005-10-13 Trw Automotive Safety Systems Gmbh Gassackmodul
EP2094268A2 (en) * 2006-05-26 2009-09-02 Bayer HealthCare, LLC Drug combinations with substituted diaryl ureas for the treatment of cancer

Also Published As

Publication number Publication date
TW200950791A (en) 2009-12-16
ZA201006082B (en) 2011-10-26
PE20091578A1 (es) 2009-10-28
CL2009000538A1 (es) 2010-03-19
JP2011513448A (ja) 2011-04-28
DE102008014109A1 (de) 2009-09-17
MX2010008982A (es) 2010-09-07
AR070974A1 (es) 2010-05-19
EP2265254A2 (de) 2010-12-29
WO2009112169A3 (de) 2010-05-14
WO2009112169A2 (de) 2009-09-17
CA2718142A1 (en) 2009-09-17
BRPI0908576A2 (pt) 2015-09-22
AU2009225055A1 (en) 2009-09-17
CN101969925A (zh) 2011-02-09
KR20100135760A (ko) 2010-12-27
US20110021641A1 (en) 2011-01-27

Similar Documents

Publication Publication Date Title
MX2010007936A (es) Anticuerpo anti-nr-10 y su uso.
IT1391530B1 (it) Particelle attive per applicazioni bio-analitiche e metodi per la loro preparazione
CL2008000377A1 (es) Compuestos derivados de ciclos fusionados sustituidos; agente farmaceutico que comprende a dichos compuestos; y uso para la prevencion o tratamiento de la diabetes.
BRPI0917006A2 (pt) agente de liberação prolongada de droga, adsorvente, alimento, máscara tendo um adsorvente, e, folha de adsorção
BR112012010676A2 (pt) partícula de alta eficiência que compreende um agente de benefício.
BRPI0816465A2 (pt) Métodos para tratamento ou prevenção de infecções do trato respiratório que compreendem a administração de colecalciferol
CL2012000391A1 (es) Uso de un anticuerpo anti-cd20 afucosilado con una cantidad de fucosa de 60% o menos de la cantidad total de oligosacaridos en asn297 para tratar cancer en combinacion con bendamustina.
CO6680609A2 (es) Composición acuosa que contiene bromhexina
EP2261261A4 (en) FINE CELLULOSE DERIVATIVE PARTICLES, LIQUID DISPERSIONS, SOLIDS, AND DIAGNOSIS AGENTS
EP2352503A4 (en) ROLE OF SOLUBLE UPAR IN THE PATHOGENESIS OF KIDNEY DISEASES WITH PROTEINURIA
WO2012028964A3 (en) Reduced graphene oxide-based-composites for the purification of water
EP2088360A4 (en) CONNECTION AND USED FOR CONNECTION (R) SOCKET AND PLUG
IL195316A0 (en) Nanoparticles of chitosan and hyaluronan for the administration of active molecules
BRPI0922203A2 (pt) autoprecipitação de composição particulada aquosa que compreende partículas de pigmento-aglutinante
ZA200805879B (en) Protection against exceeding the braking capability of remote controlled locomotives
CL2007001838A1 (es) Compuestos derivados de 4-oxoquinolina; composicion farmaceutica; y uso del compuesto para la produccion de un agente anti-vih.
SV2011003852A (es) Particulas inhalables que comprenden tiotropio
UY31692A (es) Formulacion en suspension para adsorbentes de carbono
CL2007003859A1 (es) Metodo para eliminar arsenico que comprende contactar la solucion con un agente precipitante de tierra rara para precipitar arsenico y obtener solucion parcialmente liberada de arsenico y agente cargado con arsenico,contactar la solucion separada con una segunda porcion de agente precipitante;y aparato para separar arsenico.
IL197783A0 (en) Polycyclic agents for the treatment of respiratory syncytial virus infections
CL2015000226A1 (es) Proceso para la concentracion de una suspension acuosa de particulas solidas que comprende la adicion de al menos un floculante polimerico organico a la suspension acuosa y en donde se añade al menos un agente activo a los solidos en la corriente de reciclado.
ES1066681Y (es) Dispositivo de freno para cochecitos infantiles.
GB2469429A (en) Oil filter for downhole motor
WO2013111021A3 (en) Moisture removal device for bariatric skin fold
EP2195419A4 (en) METHODS OF DRYING BACTERIOPHAGES AND COMPOSITIONS CONTAINING BACTERIOPHAGES, RESULTING DRY COMPOSITIONS AND METHODS OF USE

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20181017